Stay updated on Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and an updated Intervention/Treatment label, and it notes that recruitment is closed ('No longer looking for participants') with a revision update to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-16T05:33:43.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.5.4 to v3.5.5, indicating a small platform maintenance update. This change does not alter any study information or visible content.
    Difference
    0.0%
    Check dated 2026-06-09T03:11:49.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    Revision label updated from v3.5.3 to v3.5.4, representing a maintenance update to the page’s version. No visible changes to study information or functionality are evident.
    Difference
    0.0%
    Check dated 2026-05-18T13:51:36.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    Updates the displayed ClinicalTrials.gov page revision version in the footer (from v3.5.2 to v3.5.3).
    Difference
    0.0%
    Check dated 2026-04-26T15:34:22.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Collaborator name updated from Ono Pharmaceutical Co. Ltd to Ono Pharmaceutical Co., Ltd. Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-19T13:55:35.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. This change does not modify the study information or page functionality.
    Difference
    0.0%
    Check dated 2026-03-21T20:23:12.000Z thumbnail image

Stay in the know with updates to Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab + Brentuximab Vedotin in Hodgkin Lymphoma Clinical Trial page.